Surgical Oncology News

This section features a sampling of news related to surgical oncology from the popular press, from press releases received, or SSO news directly pertinent to SSO members.

FDA: MelaFind skin cancer biopsy replacement may cause "more harm than good"

Author: MassDevice staff, MassDevice
Nov 16, 2010

The Food & Drug Administration raises concerns over Mela Sciences Inc.'s melanoma-detection device two days ahead of its pre-market approval vote by an agency panel.

Mela Sciences Inc.'s (NSDQ:MELA) hand-held skin cancer detection device received a scathing review from the the Food & Drug Administration.

The Irvington, N.Y.-based company's MelaFind, a device designed to determine whether skin moles and lesions are cancerous - potentially eliminating the need for biopsies - is scheduled for a vote by the FDA's General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee this week, which could pave the way for the device's final pre-market approval...

Read More on This Story Here...

Read More Surgical Oncology News Stories...